tacrine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

tacrine has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, HZ; Dong, CZ; Ezoulin, MJ; Heymans, F; Lelièvre, L; Li, J; Liu, Z; Massicot, F; Ombetta, JE	1
Dong, CZ; Dutertre-Catella, H; Ezoulin, MJ; Heymans, F; Liu, Z; Massicot, F; Ombetta, JE; Rat, P; Wu, G	1

Other Studies

2 other study(ies) available for tacrine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

Article	Year
Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment. Toxicology in vitro : an international journal published in association with BIBRA, 2006, Volume: 20, Issue:6 Topics: Cell Survival; Cholinesterase Inhibitors; Furans; Galantamine; Humans; Lipid Peroxidation; Liver; Membrane Potentials; Mitochondria; Oxidative Stress; Platelet Activating Factor; Tacrine	2006
A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine. International immunopharmacology, 2007, Dec-15, Volume: 7, Issue:13 Topics: Animals; Cell Survival; Cells, Cultured; Cholinesterase Inhibitors; Chromatin; Cyclooxygenase 2 Inhibitors; Dinoprostone; Furans; Glutathione; Macrophages; Mice; Mitochondria; Nitric Oxide; Oxidative Stress; Platelet Activating Factor; Tacrine; Tumor Necrosis Factor-alpha	2007

Article

Year

Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment.

Toxicology in vitro : an international journal published in association with BIBRA, 2006, Volume: 20, Issue:6

Topics: Cell Survival; Cholinesterase Inhibitors; Furans; Galantamine; Humans; Lipid Peroxidation; Liver; Membrane Potentials; Mitochondria; Oxidative Stress; Platelet Activating Factor; Tacrine

2006

A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine.

International immunopharmacology, 2007, Dec-15, Volume: 7, Issue:13

Topics: Animals; Cell Survival; Cells, Cultured; Cholinesterase Inhibitors; Chromatin; Cyclooxygenase 2 Inhibitors; Dinoprostone; Furans; Glutathione; Macrophages; Mice; Mitochondria; Nitric Oxide; Oxidative Stress; Platelet Activating Factor; Tacrine; Tumor Necrosis Factor-alpha

2007